Your browser doesn't support javascript.
loading
Communication, Coordination, and Security for People with Multiple Sclerosis (COCOS-MS): a randomised phase II clinical trial protocol.
Golla, Heidrun; Dillen, Kim; Hellmich, Martin; Dojan, Thomas; Ungeheuer, Solveig; Schmalz, Petra; Staß, Angelika; Mildenberger, Vanessa; Goereci, Yasemin; Dunkl, Veronika; Strupp, Julia; Fink, Gereon R; Voltz, Raymond; Stock, Stephanie; Cornely, Oliver; Stahmann, Alexander; Müller, Anne; Löcherbach, Peter; Burghaus, Lothar; Limmroth, Volker; Bonmann, Eckhard; Gerbershagen, Kathrin; Nelles, Gereon; Joist, Thomas; Haas, Judith; Temmes, Herbert; Warnke, Clemens.
Afiliação
  • Golla H; Department of Palliative Medicine, University of Cologne, Cologne, Germany heidrun.golla@uk-koeln.de.
  • Dillen K; Department of Palliative Medicine, University of Cologne, Cologne, Germany.
  • Hellmich M; Institute of Medical Statistics and Computational Biology (IMSB), University of Cologne, Cologne, Germany.
  • Dojan T; Department of Palliative Medicine, University of Cologne, Cologne, Germany.
  • Ungeheuer S; Department of Palliative Medicine, University of Cologne, Cologne, Germany.
  • Schmalz P; Clinical Trials Centre Cologne (CTCC), University of Cologne, Cologne, Germany.
  • Staß A; Clinical Trials Centre Cologne (CTCC), University of Cologne, Cologne, Germany.
  • Mildenberger V; Institute for Health Economics and Clinical Epidemiology (IGKE), University of Cologne, Cologne, Germany.
  • Goereci Y; Department of Neurology, University of Cologne, Cologne, Nordrhein-Westfalen, Germany.
  • Dunkl V; Department of Palliative Medicine, University of Cologne, Cologne, Germany.
  • Strupp J; Department of Palliative Medicine, University of Cologne, Cologne, Germany.
  • Fink GR; Department of Neurology, University of Cologne, Cologne, Nordrhein-Westfalen, Germany.
  • Voltz R; Cognitive Neuroscience, Institute of Neurosciences and Medicine, Jülich, Germany.
  • Stock S; Department of Palliative Medicine, University of Cologne, Cologne, Germany.
  • Cornely O; Clinical Trials Centre Cologne (CTCC), University of Cologne, Cologne, Germany.
  • Stahmann A; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Cologne, Germany.
  • Müller A; Center for Health Services Research (ZVFK), University of Cologne, Cologne, Germany.
  • Löcherbach P; Institute for Health Economics and Clinical Epidemiology (IGKE), University of Cologne, Cologne, Germany.
  • Burghaus L; Clinical Trials Centre Cologne (CTCC), University of Cologne, Cologne, Germany.
  • Limmroth V; MS-Registry by the German MS-Society, MS Forschungs- und Projektentwicklungs-gGmbH, Hannover, Germany.
  • Bonmann E; Department of Palliative Medicine, University of Cologne, Cologne, Germany.
  • Gerbershagen K; German Society for Care and Case Management (DGCC), Mainz, Germany.
  • Nelles G; Department of Neurology, Heilig Geist-Krankenhaus Köln, Cologne, Germany.
  • Joist T; Department of Neurology, Klinikum Köln, Cologne, Germany.
  • Haas J; Department of Neurology, Klinikum Köln, Cologne, Germany.
  • Temmes H; Department of Neurology, Klinikum Köln, Cologne, Germany.
  • Warnke C; NeuroMed Campus, MedCampus Hohenlind, Cologne, Germany.
BMJ Open ; 12(1): e049300, 2022 Jan 25.
Article em En | MEDLINE | ID: mdl-35078833
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Esclerose Múltipla Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Esclerose Múltipla Idioma: En Ano de publicação: 2022 Tipo de documento: Article